Skip to content
Disclosery

Aquilo Capital Management, LLC

Follow

13F filer, CIK 1591986, SAN FRANCISCO, CA

Aquilo Capital Management, LLC reported $131,875,058 across 14 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14. Its ten largest share positions make up 89.35% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001591986-24-000007

Period
2024-09-30
Reported value
$132M
Holdings
14
Top 10 weight
89.35%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
IMTXadded+133,502$1.52M
BLUEPRINT MEDICINES CORPadded+10,000$925K
BCYCadded+25,219$571K
RGNXadded+24,460$257K
REPARE THERAPEUTICS INCadded+32,432$112K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
KYMRreduced-120,000-$5.68M
SLNreduced-183,000-$3.33M
ARWRreduced-112,661-$2.18M
MERUS N Vreduced-30,254-$1.51M
ARVNreduced-40,000-$985K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0001591986-24-000007, largest first. % of portfolio is the value over $88,843,058, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 908,474 shares; 2024Q1: 908,474 shares; 2024Q2: 908,474 shares; 2024Q3: 795,813 shares 795,813$15.4M17.35%-112,661Timeline
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 254,827 shares; 2024Q1: 182,151 shares; 2024Q2: 114,600 shares; 2024Q3: 124,600 shares 124,600$11.5M12.97%+10,000
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 881,337 shares; 2024Q1: 388,743 shares; 2024Q2: 328,743 shares; 2024Q3: 208,743 shares 208,743$9.88M11.12%-120,000Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 802,424 shares; 2024Q1: 906,248 shares; 2024Q2: 906,248 shares; 2024Q3: 930,708 shares 930,708$9.76M10.99%+24,460Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 489,153 shares; 2024Q1: 405,766 shares; 2024Q2: 428,766 shares; 2024Q3: 388,766 shares 388,766$9.58M10.78%-40,000Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 355,109 shares; 2024Q1: 255,109 shares; 2024Q2: 148,109 shares; 2024Q3: 117,855 shares 117,855$5.89M6.63%-30,254
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 1,043,284 shares; 2024Q1: 574,214 shares; 2024Q2: 500,214 shares; 2024Q3: 317,214 shares 317,214$5.77M6.49%-183,000Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 156,692 shares; 2024Q3: 181,911 shares 181,911$4.12M4.63%+25,219Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 200,000 shares; 2024Q3: 333,502 shares 333,502$3.81M4.28%+133,502Timeline
ADICET BIO INCADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 2,531,194 shares; 2024Q3: 2,531,194 shares 2,531,194$3.64M4.1%0
DTILPRECISION BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: 385,440 shares; 2024Q2: 381,803 shares; 2024Q3: 381,803 shares 381,803$3.42M3.85%0Timeline
REPARE THERAPEUTICS INCREPARE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 633,271 shares; 2024Q1: 633,271 shares; 2024Q2: 956,932 shares; 2024Q3: 989,364 shares 989,364$3.4M3.83%+32,432
SUTRO BIOPHARMA INCSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 420,649 shares; 2024Q1: 1,165,466 shares; 2024Q2: 762,498 shares; 2024Q3: 762,498 shares 762,498$2.64M2.97%0

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SPYSTATE STR SPDR S&P 500 ETF T SHSput75,000$43Mnew

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001591986-24-000007 base2024-11-14acceptance time not in the bulk data set